Advertisement
CNO vs JXN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNO is a Buy and JXN is a Hold.
CNO in upward trend: price rose above 50-day moving average on October 27, 2026
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 54 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 25 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.088) is normal, around the industry mean (1.354). P/E Ratio (19.760) is within average values for comparable stocks, (20.301). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.012) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
JXN's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for JXN turned positive on October 22, 2026. Looking at past instances where JXN's MACD turned positive, the stock continued to rise in 34 of 43 cases over the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on JXN as a result. In 63 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
JXN moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JXN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where JXN advanced for three days, in 292 of 378 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 202 of 274 cases where JXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
JXN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. JXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.989) is normal, around the industry mean (1.354). JXN's P/E Ratio (149.609) is considerably higher than the industry average of (20.301). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). Dividend Yield (0.026) settles around the average of (0.047) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
CNO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 4 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CNO | JXN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | N/A |
| Stochastic ODDS (%) | 1 day ago 53% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 63% | 1 day ago 75% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 61% | 1 day ago 77% |
| Advances ODDS (%) | 2 days ago 63% | 1 day ago 77% |
| Declines ODDS (%) | N/A | 16 days ago 63% |
| BollingerBands ODDS (%) | 1 day ago 65% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 62% | 1 day ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while JXN’s FA Score has 1 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- JXN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 6 TA indicator(s) are bullish while JXN’s TA Score has 6 bullish TA indicator(s).
- CNO’s TA Score: 6 bullish, 3 bearish.
- JXN’s TA Score: 6 bullish, 3 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а +5.42% price change this week, while JXN (@Life/Health Insurance) price change was +4.14% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.10%. For the same industry, the average monthly price growth was -0.25%, and the average quarterly price growth was -3.00%.
Reported Earning Dates
CNO is expected to report earnings on Feb 09, 2027.
JXN is expected to report earnings on Feb 24, 2027.
Industries' Descriptions
@Life/Health Insurance (+1.10% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.
JXN and
Correlation & Price change
A.I.dvisor indicates that over the last year, JXN has been loosely correlated with LNC. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if JXN jumps, then LNC could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BFLB | 55.12 | 0.11 | +0.20% |
| BufferLABS US Equity Dynamic Buffer ETF (BFLB) | |||
| YOKE | 32.05 | N/A | N/A |
| YOKE Core ETF | |||
| IUSV | 115.30 | -0.68 | -0.59% |
| iShares Core S&P US Value ETF (IUSV) | |||
| UDOW | 65.39 | -0.87 | -1.31% |
| ProShares UltraPro Dow30 (UDOW) | |||
| NVDQ | 9.71 | -0.44 | -4.38% |
| T-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ) | |||